The guidance provides information about how to view Waivers and No Objection letters in PHIS, the Agencys public health data analytic system. It applies to official establishments and the actions they may take to submit documentation related to regulatory requirements for new technology use and pathogen sampling. It relates to 9 CFR 303.1(h), 310.18, 381.3(b), 417.2, 417.4, and 590.10.